Cordlife Group Ltd P8A
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- SGD 0.13
- Day Range
- SGD 0.13–0.14
- 52-Week Range
- SGD 0.12–0.57
- Bid/Ask
- SGD 0.14 / SGD 0.14
- Market Cap
- SGD 34.60 Mil
- Volume/Avg
- 74,700 / 125,245
Key Statistics
- Price/Earnings (Normalized)
- 8.60
- Price/Sales
- 0.59
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Cordlife Group Ltd is a consumer healthcare company dedicated to safeguarding the well-being of mother and child. Cordlife has processing and storage facilities in six key markets across Asia, namely Singapore, Hong Kong, Malaysia, India, Indonesia, and the Philippines. The company has two segments - The Banking segment, which comprises cord blood, cord lining, and cord tissue services. The Diagnostics segment comprises Metascreen, which is a non-invasive metabolic screening test specially designed for newborn babies, a non-invasive prenatal testing service and Eyescreen, a paediatric eye-screening service.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Value
- Total Number of Employees
- —
- Website
- https://www.cordlife.com
Comparables
Valuation
|
Metric
|
P8A
|
7096
|
LALPATHLAB
|
|---|---|---|---|
Price/Earnings (Normalized) | 8.60 | 47.47 | 57.45 |
Price/Book Value | 0.24 | 7.25 | 11.21 |
Price/Sales | 0.59 | 7.83 | 9.31 |
Price/Cash Flow | 5.37 | 54.12 | 44.09 |
Price/Earnings
P8A
7096
LALPATHLAB
Financial Strength
|
Metric
|
P8A
|
7096
|
LALPATHLAB
|
|---|---|---|---|
Quick Ratio | 3.74 | 1.17 | 2.16 |
Current Ratio | 4.27 | 1.20 | 2.29 |
Interest Coverage | 4.13 | — | 15.74 |
Quick Ratio
P8A
7096
LALPATHLAB
Profitability
|
Metric
|
P8A
|
7096
|
LALPATHLAB
|
|---|---|---|---|
Return on Assets (Normalized) | 1.79% | 6.65% | 15.28% |
Return on Equity (Normalized) | 3.04% | 16.43% | 21.06% |
Return on Invested Capital (Normalized) | 1.06% | 16.34% | 18.51% |
Return on Assets
P8A
7096
LALPATHLAB
Diagnostics & Research Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
TMO
| Thermo Fisher Scientific Inc | Jkfvpxszw | Vlsc | $227.0 Bil | |
DHR
| Danaher Corp | Mnhwrvcnk | Zhblm | $186.4 Bil | |
A
| Agilent Technologies Inc | Pfntqdymb | Dhws | $44.3 Bil | |
IQV
| IQVIA Holdings Inc | Mjgmllfc | Zxxbmtx | $42.1 Bil | |
IDXX
| IDEXX Laboratories Inc | Crgkztcw | Chzfxh | $41.5 Bil | |
MTD
| Mettler-Toledo International Inc | Bjhmbtsnt | Vfcgws | $32.0 Bil | |
ICLR
| Icon PLC | Mmyvfywqx | Cjqmxx | $25.6 Bil | |
WAT
| Waters Corp | Jmmdrlwd | Tnf | $21.3 Bil | |
ILMN
| Illumina Inc | Qnnllfnc | Qqmkrx | $18.4 Bil | |
LH
| Laboratory Corp of America Holdings | Qjvsqsgnp | Mckhsm | $17.8 Bil |